New 52 Week Low Today

Legend Biotech Corp LEGN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
50.12UNCH (UNCH)
Volume
106,755
Close
50.12quote price arrow down-1.59 (-3.07%)
Volume
2,576,120
52 week range
48.98 - 77.32
Loading...
  • Open50.00
  • Day High50.58
  • Day Low48.98
  • Prev Close51.71
  • 52 Week High77.32
  • 52 Week High Date07/21/23
  • 52 Week Low48.98
  • 52 Week Low Date04/16/24

Key Stats

  • Market Cap9.117B
  • Shares Out181.91M
  • 10 Day Average Volume0.85M
  • Dividend-
  • Dividend Yield-
  • Beta0.04
  • YTD % Change-16.7

KEY STATS

  • Open50.00
  • Day High50.58
  • Day Low48.98
  • Prev Close51.71
  • 52 Week High77.32
  • 52 Week High Date07/21/23
  • 52 Week Low48.98
  • 52 Week Low Date04/16/24
  • Market Cap9.117B
  • Shares Out181.91M
  • 10 Day Average Volume0.85M
  • Dividend-
  • Dividend Yield-
  • Beta0.04
  • YTD % Change-16.7

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-30.01
  • EBITDA (TTM)-517.444M
  • ROE (TTM)-51.94%
  • Revenue (TTM)285.143M
  • Gross Margin (TTM)49.42%
  • Net Margin (TTM)-181.75%
  • Debt To Equity (MRQ)26.26%

EVENTS

  • Earnings Date05/13/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Legend Biotech Corp

 

Profile

MORE
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including...
Fangliang Zhang Ph.D.
Chairman of the Board
Ying Huang Ph.D.
Chief Executive Officer, Director
Lori Macomber CPA
Chief Financial Officer
Address
2101 Cottontail Lane
Somerset, NJ
08873
United States